Facile conversion of racemic ibuprofen to (S)-ibuprofen

被引:19
|
作者
Chavez-Flores, David [1 ]
Salvador, James M. [1 ]
机构
[1] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA
关键词
D O I
10.1016/j.tetasy.2012.02.014
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The methyl ester of ibuprofen was quantitatively formed by Fischer esterification and converted into (S)-ibuprofen in 94% yield with an ee of 94% under dynamic kinetic resolution conditions at pH 9.8, using Candida rugosa lipase, and 20% DMSO. The (R)-methyl ibuprofen ester was observed to racemize by chiral HPLC without the Candida rugosa lipase present. The rates of in situ racemization and enzymatic hydrolysis for the dynamic kinetic resolution were determined to be 0.026 +/- 0.004 and 0.053 +/- 0.004 h(-1), respectively. The rate of enzymatic hydrolysis when no DMSO was present was twice as fast but no racemization occurred. A facile purification of enriched (S)-ibuprofen was developed. Overall, 88% of racemic ibuprofen by weight was converted into (S)-ibuprofen with an ee of 99.7%. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:237 / 239
页数:3
相关论文
共 50 条
  • [31] Study on the enzymatic hydrolysis of racemic methyl ibuprofen ester
    Madhav, MV
    Ching, CB
    JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY, 2001, 76 (09) : 941 - 948
  • [32] Solubility of (±)-ibuprofen and S (±)-ibuprofen in the presence of cosolvents and cyclodextrins
    Nerurkar, J
    Beach, JW
    Park, MO
    Jun, HW
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2005, 10 (03) : 413 - 421
  • [33] Candida Rugosa Lipase Catalyzed Esterification of Racemic Ibuprofen with Butanol: Racemization of R-Ibuprofen and Chemical Hydrolysis of S-Ester Formed
    Yu-Chun Xie
    Hui-Zhou Liu
    Jia-Yong Chen
    Biotechnology Letters, 1998, 20 : 455 - 458
  • [34] Candida rugosa lipase catalyzed esterification of racemic ibuprofen with butanol:: racemization of R-ibuprofen and chemical hydrolysis of S-ester formed
    Xie, YC
    Liu, HZ
    Chen, JY
    BIOTECHNOLOGY LETTERS, 1998, 20 (05) : 455 - 458
  • [35] LACK OF PRESYSTEMIC INVERSION OF (R)-IBUPROFEN TO (S)-IBUPROFEN IN HUMANS
    HALL, SD
    RUDY, AC
    KNIGHT, PM
    BRATER, DC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (04) : 393 - 400
  • [36] STRUCTURE OF (S)-(+)-IBUPROFEN
    FREER, AA
    BUNYAN, JM
    SHANKLAND, N
    SHEEN, DB
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1993, 49 : 1378 - 1380
  • [37] LACK OF EFFECT OF CIMETIDINE ON THE PHARMACOKINETICS OF R(-)-IBUPROFEN AND S(+)-IBUPROFEN
    EVANS, AM
    NATION, RL
    SANSOM, LN
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (02) : 143 - 149
  • [38] Enzymatic kinetic resolution of racemic ibuprofen: past, present and future
    Jose, Carla
    Victoria Toledo, Maria
    Briand, Laura E.
    CRITICAL REVIEWS IN BIOTECHNOLOGY, 2016, 36 (05) : 891 - 903
  • [39] BIOAVAILABILITY OF RACEMIC IBUPROFEN AND ITS LYSINATE FROM SUPPOSITORIES IN RABBITS
    HERMANN, TW
    GTOWKA, FK
    GARRETT, ER
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (11) : 1102 - 1111
  • [40] Kinetics of Lipase Catalyzed Enantioselective Esterification of Racemic Ibuprofen in Isooctane
    谢渝春
    刘会洲
    陈家镛
    ChineseJournalofChemicalEngineering, 2000, (01) : 10 - 18